52221-07-5

Usage

Uses

Used in Plasticizer and Solvent Applications:
Hexanedioic acid, mono(1,1-dimethylethyl) ester is used as a plasticizer and solvent in the production of resins, plasticizers, and synthetic lubricants. It helps to improve the flexibility, workability, and performance of these materials.
Used in Adhesives Industry:
In the adhesives industry, Hexanedioic acid, mono(1,1-dimethylethyl) ester is used as a component in the formulation of adhesives to enhance their bonding strength and durability.
Used in Paints and Coatings Industry:
Hexanedioic acid, mono(1,1-dimethylethyl) ester is used in the manufacturing of paints and coatings as a solvent to dissolve cellulose acetate, nitrocellulose, and other synthetic resins. It contributes to the improved flow, leveling, and drying properties of the paint and coating formulations.
Used in Synthetic Lubricants Industry:
In the synthetic lubricants industry, Hexanedioic acid, mono(1,1-dimethylethyl) ester is used as a component to improve the viscosity, stability, and performance of the lubricants under various operating conditions.
Overall, Hexanedioic acid, mono(1,1-dimethylethyl) ester is a versatile and widely used compound in various industries, including plastics, adhesives, paints, coatings, and synthetic lubricants, due to its unique properties and low toxicity.

Upstream product

• 124-04-9 Adipic acid 
• 75-65-0 tert-butyl alcohol 
• 626-86-8 adipinic acid monoethyl ester 
• 865-47-4 potassium tert-butylate 
• 627-91-8 adipic acid monomethyl ester 
• 52221-08-6 5-Methoxycarbonylpentansaeure-tert-butylester 

Downstream Products

• 124-04-9 Adipic acid 
• 115-11-7 isobutene 
• 234081-72-2 5-[(S)-1-Benzyloxycarbonyl-2-((S)-1,2-bis-hexadecylcarbamoyl-ethylcarbamoyl)-ethylcarbamoyl]-pentanoic acid tert-butyl ester 
• 234081-82-4 5-[(S)-1-Benzyloxycarbonyl-2-((S)-1,2-bis-hexadecylcarbamoyl-ethylcarbamoyl)-ethylcarbamoyl]-pentanoic acid 
• 1373278-34-2 2-(6-tert-butoxy-6-oxohexanamido)-4-(methoxycarbonyl)benzoic acid 
• 1373278-36-4 methyl 2-(5-tert-butoxy-5-oxopentyl)-4-oxo-3-p-tolyl3,4-dihydroquinazoline-7-carboxylate 

Relevant academic research and scientific papers

PANTETHEINE DERIVATIVES AND USES THEREOF

The present disclosure relates to compounds of Formula (I), (II), or (II'): (I), (II), (II'), and pharmaceutically acceptable salts or solvates thereof. The present disclosure also relates to pharmaceutical compositions comprising the compounds and therapeutic and diagnostic uses of the compounds and pharmaceutical compositions.

QUINAZOLINONE-TYPE COMPOUNDS AS CRTH2 ANTAGONISTS

This application provides for compounds of the formula Formula I or a pharmaceutically acceptable salt thereof, wherein the individual variables are defined herein, as well as processes to prepare these compounds, pharmaceutical compositions comprising the same and their use in treating disease state associated with the CRTH2 receptor.

Trigger lipids inducing pH-dependent liposome fusion

Aspartic acid-derived artificial lipids (ADLs; s indicates the number of the methylene groups, s=2, 4, 6, 8, 10, 12) (Scheme 1) with various carboxyl alkyl chains as head groups are designed and synthesized, which are incorporated into liposome membranes by sonication. Fluorescence resonance energy transfer (FRET) measurements indicate that ADL6, ADL8 and ADL10 have high lipid-mixing ability in the acidic solution. The other ADLs, however, do not induce remarkable liposome fusion at acidic nor neutral pH. The hydrophobicity of the head groups of ADL6, ADL8 and ADL10 is suitable as triggers of membrane fusion.

Process for preparation of dicarboxylic acid monoesters

A process for producing a dicarboxylic acid monoester which comprises subjecting a dicarboxylic acid monoester or an alkali metal salt of a dicarboxylic acid monoester and a metal alkoxide to transesterification in the presence of an organic solvent, or a process for producing a dicarboxylic acid monoester which comprises subjecting a dicarboxylic acid monoester or an alkali metal salt of a dicarboxylic acid monoester and an alcohol to transesterification in the presence of a metal alkoxide.

Alpha-and beta-substituted trifluoromethyl ketones as phospholipase inhibitors

Inhibitors of the cytosolic phospholipase A2 enzymes are provided which are of use in controlling a wide variety of inflammatory diseases. The inhibitors of the present invention have the general formula where X, Z, R1, R2, R3, R4, Raand Rbare as defined in the specification.

Alpha-and beta- substituted trifluoromethyl ketones as phospholipase inhibitors

Inhibitors of the cytosolic phospholipase A2 enzymes are provided which are of use in controlling a wide variety of inflammatory diseases. The inhibitors of the present invention have the general formula where X, Z, R1, R2, R3, R4, Ra and Rb are as defined in the specification.

Non-peptidic liposome-fusion compounds at acidic pH

Liposomes including aspartic acid-derived artificial lipids (ADL) with various carboxy alkyl chains as head groups (ADLn; n indicates the number of the methylene groups, n = 2,4,6,8,10,12) are prepared, in which ADL6 and ADL8 liposomes induce remarkably high lipid-mixing in the acidic region.